Register for our free email digests:
Teva acquires Sicor for $3.3bn in cash and stock
- Generic Drugs
- Payment Includes Stock
- Payment Includes Cash
- Full Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.